Aspirin, Blood Pressure Control, Cholesterol, and Diabetes Management Metrics
| Domain | Description | Description - Full | NQF |
|---|---|---|---|
| Aspirin | Aspirin for CVD | Percentage of patients 18 years of age and older who were diagnosed with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months before the measurement period, or who had an active diagnosis of ischemic vascular disease (IV.D) during the measurement period, and who had documentation of use of aspirin or another antiplatelet during the measurement period | 0068 |
| Blood Pressure | Hypertension control < 140/90 mm Hg | Percentage of patients 18 to 85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (< 140/90 mm Hg) during the measurement period | 0018 |
| Cholesterol | Statin therapy | Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period: • Adults aged ≥ 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD); OR • Adults aged ≥ 21 years who have ever had a fasting or direct low-density lipoprotein cholesterol (LDL-C) level ≥ 190 mg/dL; OR • Adults aged 40 to 75 years with a diagnosis of diabetes with a fasting or direct LDL-C level of 70 to 189 mg/dL | None |
| Diabetes | Poorly controlled (HbA1c > 9) | Percentage of patients 18 to 75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period OR had no measured HbA1c during the measurement period | 0059 |
Abbreviation: NQF, National Quality Forum.